Table 3. Survival, according to risk... | American Society of Hematology

Table 3.

Survival, according to risk factors, in all patients and in patients with primary MDS

Risk Factor	All Patients (n = 50)		Patients with Primary MDS (n = 42)
Risk Factor	Patients Surviving/ Total No. of Patients	KM Estimate of RFS at 3 y	Patients Surviving/ Total No. of Patients at Risk	KM Estimate of RFS at 3 y
Source of stem cells
HLA-identical sibling	17/36	0.39	16/30	0.47
HLA-nonidentical relative	0/4	0.00	0/3	0.00
Syngeneic donor	2/4	0.67^3-150	2/3	1.00^3-150
Unrelated donor	3/6	0.50	3/6	0.50
Etiology of MDS
Primary	21/42	0.38	—	—
Secondary	1/8	0.13	—	—
FAB classification
RA	7/13	0.53	7/12	0.57
RAEB	9/19	0.46	9/17	0.52
RAEB-T/AML	6/16	0.38^3-150	5/11	0.45^3-150
CMML	0/2	0.00	0/2	0.00
Cytogenetic risk^3-151
Low	13/24	0.45	12/22	0.50
Intermediate	5/7	0.71	5/6	0.83
High	3/15	0.21^3-150	3/11	0.30^3-150
IPSS^3-152
Low (0)	1/2	0.50	1/1	1.00
Intermediate 1 (0.5-1)	7/14	0.50	7/13	0.54
Intermediate 2 (1.5-2.0)	10/19	0.41	10/18	0.44
High (>2.5)	3/10	0.27^3-150	2/6	0.50^3-150

Risk Factor	All Patients (n = 50)		Patients with Primary MDS (n = 42)
Risk Factor	Patients Surviving/ Total No. of Patients	KM Estimate of RFS at 3 y	Patients Surviving/ Total No. of Patients at Risk	KM Estimate of RFS at 3 y
Source of stem cells
HLA-identical sibling	17/36	0.39	16/30	0.47
HLA-nonidentical relative	0/4	0.00	0/3	0.00
Syngeneic donor	2/4	0.67^3-150	2/3	1.00^3-150
Unrelated donor	3/6	0.50	3/6	0.50
Etiology of MDS
Primary	21/42	0.38	—	—
Secondary	1/8	0.13	—	—
FAB classification
RA	7/13	0.53	7/12	0.57
RAEB	9/19	0.46	9/17	0.52
RAEB-T/AML	6/16	0.38^3-150	5/11	0.45^3-150
CMML	0/2	0.00	0/2	0.00
Cytogenetic risk^3-151
Low	13/24	0.45	12/22	0.50
Intermediate	5/7	0.71	5/6	0.83
High	3/15	0.21^3-150	3/11	0.30^3-150
IPSS^3-152
Low (0)	1/2	0.50	1/1	1.00
Intermediate 1 (0.5-1)	7/14	0.50	7/13	0.54
Intermediate 2 (1.5-2.0)	10/19	0.41	10/18	0.44
High (>2.5)	3/10	0.27^3-150	2/6	0.50^3-150

RFS denotes relapse-free survival; IPSS, International Prognostic Scoring System.

One patient died 3.1 years after transplantation.

Not available in 4 patients.

Variables incomplete in 5 patients.